购物车
- 全部删除
- 您的购物车当前为空
GPR183-IN-2 (compound 23) 作为一种有效口服活性GPR183抑制剂,能够抑制Ca2+动员,其IC50为39.45 nM。该化合物在癌症、自身免疫疾病、疼痛及骨质疏松症研究中显示出潜在应用价值。
GPR183-IN-2 (compound 23) 作为一种有效口服活性GPR183抑制剂,能够抑制Ca2+动员,其IC50为39.45 nM。该化合物在癌症、自身免疫疾病、疼痛及骨质疏松症研究中显示出潜在应用价值。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | GPR183-IN-2 (compound 23) is an effective, orally active inhibitor of GPR183, displaying an IC50 value of 39.45 nM in Ca2+ mobilization assays. This compound has potential applications in research related to cancer, autoimmune diseases, pain, and osteoporosis. |
分子量 | 407.3 |
分子式 | C19H23BrN2O3 |
CAS No. | 2924064-10-6 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容